UBS AM
ARQT icon

UBS AM’s Arcutis Biotherapeutics ARQT Stock Holding History

UBS AM’s Portfolio ARQT Stock Details ARQT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.59M Buy
237,171
+5,437
+2% +$139K ﹤0.01% 1517
2025
Q4 		$6.73M Sell
231,734
-12,281
-5% -$314K ﹤0.01% 1306
2025
Q3 		$4.6M Sell
244,015
-160,721
-40% -$2.53M ﹤0.01% 1408
2025
Q2 		$5.67M Buy
404,736
+125,689
+45% +$1.76M ﹤0.01% 1653
2025
Q1 		$4.36M Sell
279,047
-1,053
-0.4% -$14.8K ﹤0.01% 1640
2024
Q4 		$3.9M Buy
280,100
+3,409
+1% +$37.4K ﹤0.01% 1732
2024
Q3 		$2.57M Buy
276,691
+2,912
+1% +$28.7K ﹤0.01% 1918
2024
Q2 		$2.55M Buy
+273,779
New +$2.48M ﹤0.01% 1867
2023
Q4 		– Sell
-81,080
Closed -$431K – 2545
2023
Q3 		$431K Buy
81,080
+21,465
+36% +$183K ﹤0.01% 2349
2023
Q2 		$656K Hold
59,615
– – ﹤0.01% 2214
2023
Q1 		$656K Buy
59,615
+25,899
+77% +$375K ﹤0.01% 2214
2022
Q4 		$499K Buy
33,716
+14,616
+77% +$255K ﹤0.01% 2177
2022
Q3 		$365K Sell
19,100
-10,872
-36% -$246K ﹤0.01% 2451
2022
Q2 		$639K Hold
29,972
– – ﹤0.01% 2194
2022
Q1 		$577K Hold
29,972
– – ﹤0.01% 2414
2021
Q4 		$622K Hold
29,972
– – ﹤0.01% 2458
2021
Q3 		$716K Hold
29,972
– – ﹤0.01% 2331
2021
Q2 		$818K Buy
29,972
+8,772
+41% +$247K ﹤0.01% 2323
2021
Q1 		$613K Buy
+21,200
New +$662K ﹤0.01% 2317

Other funds holding ARQT

SCM
Suvretta Capital Management New York $3.69B AUM 86.67% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $8.16B AUM 68.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $22.9B AUM 115.26% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return